The Kansas City, Kansas, company received a loan that will fund operations through next year, when it aims to submit its ADHD drug for FDA approval.

Topics:  kansas city   kansas   adhd   fda   kansas    submit   
BING NEWS:
  • Cingulate secures capital ahead of 2025 plans to submit drug for FDA approval
    A KCK pharmaceutical company gets a cash injection that should sustain it long enough to get an ADHD drug to the FDA for approval.
    12/24/2024 - 5:25 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News